- Home
- Software
- north america
- immunotherapeutic
Show results for
Refine by
Immunotherapeutic Software In North America
3 software items found
by:Certara based inPrinceton, NEW JERSEY (USA)
Biological medicines (“biologics” or “large molecule drugs”) now account for 30% of new drug approvals and up to 50% of the pharmaceutical industry’s pipeline. Biologics differ from small molecules because they are much larger, have slower absorption rates, confined distribution, and different elimination. They are designed for a specific target, typically found on ...
by:Immunai based inNew York, NEW YORK (USA)
Immunai’s end-to-end single-cell platform enables high resolution profiling of the immune system at industrial scale, generating biological insights that accelerate R&D and power novel ...
by:Cypre, Inc. based inSan Francisco, CALIFORNIA (USA)
Cypre’s 3D Tumor Models combine the tumor, stromal and immune compartments in a high throughput format to screen targeted drugs and immunotherapy. In 2021, we partnered with Charles River to offer our 3D Tumor Models for drug discovery and preclinical screening services. Cypre Panels rapidly screen small molecules, biologics and cell therapy in 3D hydrogel in vitro tumor models. ...